EGFR and non-small cell lung carcinoma: Here, we propose an extensive review of the literature about molecular mechanisms of EGFR-TKI resistance in EGFR-mutated NSCLC, with a focus on biological diagnostic and monitoring, including the place of new molecular technologies and liquid biopsies.